|
FDA Gives Makers of Unapproved Drugs Last Chance to Request Hearings
The FDA is giving manufacturers of prescription anti-spasmodic, gastrointestinal and hypertension medications that were cited as unapproved drugs decades ago until Aug. 23 to inform the agency if they still want to appeal its decision on the need for an NDA.
This article is viewable by subscribers only. To view this article, please select an option below.
|
Subscribe
Archives